The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2

Blood. 1997 Dec 1;90(11):4588-97.

Abstract

The CXC-chemokines interleukin-8 (IL-8), neutrophil-activating peptide-2 (NAP-2), and melanoma growth-stimulatory activity (MGSA) are chemoattractants with high selectivity for neutrophils. Although IL-8 has been shown to act as an extremely potent mediator, reports on NAP-2 and MGSA are still contradictory. Here we show for the first time that NAP-2 and MGSA induce two distinct optima of neutrophil chemotaxis. A first optimum is elicited within a concentration range as low as it is characteristic for IL-8. However, a second optimum appears at more than 200-fold higher stimulus concentrations, at which IL-8 is inactive. Investigating the involvement of the two chemokine receptors CXCR-1 and CXCR-2 in NAP-2-mediated chemotaxis, we observe that the cells become desensitized to the first optimum of the chemokine after selective downregulation of CXCR-2, while both optima disappear upon simultaneous downregulation of both receptors. Blocking monoclonal antibodies (MoAbs) specific for CXCR-2 or CXCR-1 either suppress the first optimum of NAP-2-induced chemotaxis or drastically reduce the second one, respectively. These results provide evidence that both receptors are involved in NAP-2-induced neutrophil chemotaxis, with CXCR-2 rendering the cells responsive to low dosages of the chemokine, and with CXCR-1 extending their responsiveness to NAP-2 dosages higher by several orders of magnitude.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Antigens, CD / metabolism*
  • Binding Sites
  • Chemokine CXCL1
  • Chemokines / pharmacology*
  • Chemokines, CXC*
  • Chemotactic Factors / pharmacology*
  • Chemotaxis, Leukocyte / drug effects*
  • Flow Cytometry
  • Growth Inhibitors / pharmacology*
  • Growth Substances / pharmacology*
  • Humans
  • Intercellular Signaling Peptides and Proteins*
  • Interleukin-8 / metabolism*
  • Neoplasm Proteins / pharmacology*
  • Neutrophils / chemistry
  • Neutrophils / cytology
  • Neutrophils / drug effects*
  • Peptides / pharmacology*
  • Receptors, Chemokine / analysis
  • Receptors, Interleukin / analysis
  • Receptors, Interleukin / metabolism*
  • Receptors, Interleukin-8A
  • Receptors, Interleukin-8B
  • Recombinant Proteins / metabolism
  • beta-Thromboglobulin

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • CXCL1 protein, human
  • Chemokine CXCL1
  • Chemokines
  • Chemokines, CXC
  • Chemotactic Factors
  • Growth Inhibitors
  • Growth Substances
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-8
  • Neoplasm Proteins
  • PPBP protein, human
  • Peptides
  • Receptors, Chemokine
  • Receptors, Interleukin
  • Receptors, Interleukin-8A
  • Receptors, Interleukin-8B
  • Recombinant Proteins
  • beta-Thromboglobulin
  • connective tissue-activating peptide